IWC
ACRS icon

Integrated Wealth Concepts’s Aclaris Therapeutics ACRS Stock Holding History

Integrated Wealth Concepts’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12K Buy
+211
New +$941 ﹤0.01% 5507

Other funds holding ACRS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Integrated Wealth Concepts's ACRS Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Aclaris Therapeutics (ACRS) in Q2 2026: 211 shares worth $1.12K. The stake represents ﹤0.01% of the portfolio and ranks #5507 among its holdings.

149 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • Integrated Wealth Concepts held 211 shares of Aclaris Therapeutics worth $1.12K as of Q2 2026.
  • Aclaris Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Aclaris Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5507 holding.
  • 149 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.